Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 29, 2024 - Issue 2
Submit an article Journal homepage
2,270
Views
0
CrossRef citations to date
0
Altmetric
Mini-review

Evaluating emerging drugs in phase II & III for the treatment of amyotrophic lateral sclerosis

Xiaoyan LiDepartment of Neurology, Duke University, Durham, NC, USAView further author information
&
Richard BedlackDepartment of Neurology, Duke University, Durham, NC, USACorrespondence[email protected]
View further author information
Pages 93-102 | Received 19 Nov 2023, Accepted 18 Mar 2024, Published online: 22 Mar 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.